Corrigendum to “A narrative review of approved and emerging anti-obesity medications” [Saudi Pharm. J. 31(10) (2023) 101757]

Semira Abdi Beshir; Asim Ahmed Elnour; Aadith Soorya; Affana Parveen Mohamed; Sheron Sir Loon Goh; Nadia Hussain; Amal H.I. Al Haddad; Faizah Hussain; Israa Yousif EL Khidir; Zainab Abdelnassir

doi:10.1016/j.jsps.2024.102047

Citations

390

Views

Abstract not available for this publication.

Cite this Article (APA)

Semira, A. B., Asim, A. E., Aadith, S., Affana, P. M., Sheron, S. L. G., Nadia, H., Amal, H. A. H., Faizah, H., Israa, Y. E. K., Zainab, A. (2024). Corrigendum to “A narrative review of approved and emerging anti-obesity medications” [Saudi Pharm. J. 31(10) (2023) 101757]. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.102047